AG
CORT icon

Algert Global’s Corcept Therapeutics CORT Stock Holding History

Algert Global’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,058
Closed -$1.12M – 1189
2025
Q4 		$1.12M Sell
32,058
-41,010
-56% -$3.22M 0.02% 828
2025
Q3 		$6.07M Buy
73,068
+31,580
+76% +$2.29M 0.1% 354
2025
Q2 		$3.04M Buy
41,488
+2,160
+5% +$157K 0.06% 491
2025
Q1 		$4.49M Hold
39,328
– – 0.11% 311
2024
Q4 		$1.98M Sell
39,328
-787
-2% -$41.2K 0.05% 611
2024
Q3 		$1.86M Buy
40,115
+27,430
+216% +$975K 0.05% 572
2024
Q2 		$412K Buy
+12,685
New +$347K 0.01% 986
2024
Q1 		– Sell
-122,120
Closed -$3.97M – 1112
2023
Q4 		$3.97M Buy
122,120
+33,960
+39% +$932K 0.16% 207
2023
Q3 		$2.4M Buy
88,160
+5,446
+7% +$158K 0.11% 304
2023
Q2 		$1.84M Buy
82,714
+65,610
+384% +$1.51M 0.08% 413
2023
Q1 		$370K Sell
17,104
-85,520
-83% -$1.87M 0.02% 897
2022
Q4 		$2.08M Buy
102,624
+2,910
+3% +$72.9K 0.12% 282
2022
Q3 		$2.56M Buy
99,714
+6,990
+8% +$187K 0.15% 201
2022
Q2 		$2.21M Buy
92,724
+23,014
+33% +$501K 0.17% 156
2022
Q1 		$1.57M Buy
69,710
+44,790
+180% +$953K 0.1% 323
2021
Q4 		$493K Buy
+24,920
New +$506K 0.06% 544

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Algert Global's CORT Position: Q1 2026 in Review

Algert Global sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 32,058 shares — an estimated $1.12M sold.

Algert Global first reported a position in CORT in Q4 2021 and held it in 16 quarters. The position peaked at $6.07M in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Algert Global reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 32,058 Corcept Therapeutics shares in Q1 2026, an estimated $1.12M.
  • Algert Global first reported a position in Corcept Therapeutics in Q4 2021 and held it in 16 quarters.
  • Algert Global's Corcept Therapeutics position peaked at $6.07M in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.